Whither the patient-oriented researcher?

Same author

Progression of skin-limited pediatric-onset discoid lupus erythematosus to diagnosis of systemic lupus erythematosus: results of a multicenter, retrospective cohort study.

Journal of the American Academy of Dermatology·2026

Same author

Bullous pemphigoid burden of disease, management and unmet therapeutic needs.

Journal of the European Academy of Dermatology and Venereology : JEADV·2024

Same author

Phase 2 BELIEVE study part B: Efficacy and safety of rilzabrutinib for patients with pemphigus vulgaris.

Journal of the European Academy of Dermatology and Venereology : JEADV·2022

Same author

Cross-sectional characteristics of pediatric-onset discoid lupus erythematosus: Results of a multicenter, retrospective cohort study.

Journal of the American Academy of Dermatology·2022

Same author

Postinflammatory hyperpigmentation and erythema: new insights into the pathogenesis.

The British journal of dermatology·2021

Same author

Immunological and clinical heterogeneity in cutaneous lupus erythematosus.

The British journal of dermatology·2021

Same journal

Hypoactive Sexual Desire Disorder in Menopausal Women: Dermatologic Implications of Antiandrogen and Testosterone Therapy.

Journal of the American Academy of Dermatology·2026

Same journal

Incise parallel, section perpendicular to the dermatoglyphs for diagnosis of acral melanocytic lesions-A comment on Thakker et al.

Journal of the American Academy of Dermatology·2026

Same journal

Response to Xue et al, "Defining super-responders is not the same as predicting rituximab response in pemphigus".

Journal of the American Academy of Dermatology·2026

Same journal

Comment on Nie et al. (2026) 'Suicidality Reports in Acne Patients Treated with Isotretinoin and Concomitant Antidepressants: A Descriptive Analysis of FDA Adverse Event Reporting System Data'.

Journal of the American Academy of Dermatology·2026

Same journal

Defining super-responders is not the same as predicting rituximab response in pemphigus.

Journal of the American Academy of Dermatology·2026

Same journal

Eosinophilic fasciitis induced by checkpoint inhibitors: a retrospective multicenter case-series, comparison with eosinophilic fasciitis unrelated to checkpoint inhibition and literature review.

Journal of the American Academy of Dermatology·2026

Related Experiment Videos

Whither the patient-oriented researcher?

Related Concept Videos

Progression of skin-limited pediatric-onset discoid lupus erythematosus to diagnosis of systemic lupus erythematosus: results of a multicenter, retrospective cohort study.

Bullous pemphigoid burden of disease, management and unmet therapeutic needs.

Phase 2 BELIEVE study part B: Efficacy and safety of rilzabrutinib for patients with pemphigus vulgaris.

Cross-sectional characteristics of pediatric-onset discoid lupus erythematosus: Results of a multicenter, retrospective cohort study.

Postinflammatory hyperpigmentation and erythema: new insights into the pathogenesis.

Immunological and clinical heterogeneity in cutaneous lupus erythematosus.

Hypoactive Sexual Desire Disorder in Menopausal Women: Dermatologic Implications of Antiandrogen and Testosterone Therapy.

Incise parallel, section perpendicular to the dermatoglyphs for diagnosis of acral melanocytic lesions-A comment on Thakker et al.

Response to Xue et al, "Defining super-responders is not the same as predicting rituximab response in pemphigus".

Comment on Nie et al. (2026) 'Suicidality Reports in Acne Patients Treated with Isotretinoin and Concomitant Antidepressants: A Descriptive Analysis of FDA Adverse Event Reporting System Data'.

Defining super-responders is not the same as predicting rituximab response in pemphigus.

Eosinophilic fasciitis induced by checkpoint inhibitors: a retrospective multicenter case-series, comparison with eosinophilic fasciitis unrelated to checkpoint inhibition and literature review.

Related Experiment Videos

Whither the patient-oriented researcher?

Related Concept Videos

Related Articles

Progression of skin-limited pediatric-onset discoid lupus erythematosus to diagnosis of systemic lupus erythematosus: results of a multicenter, retrospective cohort study.

Bullous pemphigoid burden of disease, management and unmet therapeutic needs.

Phase 2 BELIEVE study part B: Efficacy and safety of rilzabrutinib for patients with pemphigus vulgaris.

Cross-sectional characteristics of pediatric-onset discoid lupus erythematosus: Results of a multicenter, retrospective cohort study.

Postinflammatory hyperpigmentation and erythema: new insights into the pathogenesis.

Immunological and clinical heterogeneity in cutaneous lupus erythematosus.

Hypoactive Sexual Desire Disorder in Menopausal Women: Dermatologic Implications of Antiandrogen and Testosterone Therapy.

Incise parallel, section perpendicular to the dermatoglyphs for diagnosis of acral melanocytic lesions-A comment on Thakker et al.

Response to Xue et al, "Defining super-responders is not the same as predicting rituximab response in pemphigus".

Comment on Nie et al. (2026) 'Suicidality Reports in Acne Patients Treated with Isotretinoin and Concomitant Antidepressants: A Descriptive Analysis of FDA Adverse Event Reporting System Data'.

Defining super-responders is not the same as predicting rituximab response in pemphigus.

Eosinophilic fasciitis induced by checkpoint inhibitors: a retrospective multicenter case-series, comparison with eosinophilic fasciitis unrelated to checkpoint inhibition and literature review.